N-allyl-2-chloro-N-methylacetamide | 112825-97-5

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: N-allyl-2-chloro-N-methylacetamide
• 英文别名: N-allyl-α-chloro-N-methylacetamide；N-allyl-N-methylchloroacetamide；2-Chloro-N-methyl-N-(prop-2-en-1-yl)acetamide；2-chloro-N-methyl-N-prop-2-enylacetamide
• CAS: 112825-97-5
• 化学式: C₆H₁₀ClNO
• 分子量: 147.605
• InChiKey: GANGOCMXLRYLOL-UHFFFAOYSA-N

物化性质

• 沸点：
  203.3±33.0 °C(Predicted)
• 密度：
  1.066±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  9
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  N-allyl-2-chloro-N-methylacetamide 在 sodium iodide 作用下， 以 丙酮 为溶剂， 生成 N-allyl-N-methyliodoacetamide
  参考文献：
  名称：

  Effects of temperature on atom transfer cyclization reactions of allylic .alpha.-iodo esters and amides

  摘要：

  Atom-transfer cyclizations of allyl iodoacetates and N-allyl-N-methyliodoacetamides are much more efficient at 80-degrees-C than at 25-degrees-C. At 80-degrees-C, beta-(iodomethyl) lactones and lactams are formed rapidly and in good yield under standard atom-transfer conditions (sunlamp irradiation of iodide and 10% hexabutylditin in benzene for 10-60 min). It is proposed that this temperature effect is responsible for some unusual observations by Jolly and Livinghouse in the cyclization of N-cyclohexenyl-N-methyliodoacetamide. The results suggest that the beneficial effect of temperature arises because an increase in the rate of rotation of the OC-O or OC-N bond in the intermediate radicals begins to convert syn radicals (which cannot cyclize) to anti radicals (which can cyclize). Consistent with this hypothesis, the radical derived from N,N-diallyliodoacetamide (which always has a favorable arrangement for cyclization) closes with excellent efficiency at 25-degrees-C.

  DOI：

  10.1021/jo00008a032
• 作为产物：
  描述：

  N-甲基烯丙基胺 、 氯乙酰氯 生成 N-allyl-2-chloro-N-methylacetamide
  参考文献：
  名称：

  Sato, Tatsunori; Wada, Yasuko; Nishimoto, Mami, Journal of the Chemical Society. Perkin transactions I, 1989, p. 879 - 886

  摘要：

  DOI：

文献信息

• Chemical compounds
  申请人：Imperial Chemical Industries PLC

  公开号：US04999377A1

  公开（公告）日：1991-03-12

  2-(2-Hydroxy-3-phenoxypropylamino)ethylphenoxyacetamide compounds are disclosed as useful in the treatment of obesity and related conditions. Processes for their preparation are described, as are novel intermediates and pharmaceutical compositions containing them.

  2-(2-羟基-3-苯氧基丙基氨基)乙基苯氧乙酰胺化合物被披露为治疗肥胖和相关疾病的有效药物。描述了它们的制备方法，以及包含它们的新型中间体和药物组合物。
• Diels–Alder reactions of pyridinone o-quinodimethanes generated from substituted sulfolene[3,4-c]pyridin-4(1H)-ones
  作者：Tom C Govaerts、Ilse A Vogels、Frans Compernolle、Georges J Hoornaert

  DOI：10.1016/s0040-4020(03)00826-3

  日期：2003.7

  converted to [3,4-c] sulfolene pyridinone 8a and further (1- or 3-) substituted derivatives having a dienophilic side chain on the sulfolene ring. Thermolytic extrusion of sulfur dioxide from o-QDM precursor 8 led to generation of 3,4-dimethylene-2(1H)-pyrazinone 9, which was reacted in situ with various dienophiles. Thermolysis of the substituted precursors resulted in intramolecular cycloaddition of the corresponding

  将1-苄基-3-（溴甲基）-2（1 H）-吡嗪酮转化为[3,4- c ]环丁砜8a以及在环丁烯环上具有亲二烯键的其他（1-或3-）取代衍生物。从邻-QDM前体8热挤出二氧化硫导致产生3，4-二亚甲基-2（1H）-吡嗪酮9，其与各种亲二烯体原位反应。取代的前体的热解导致相应的o -QDM中间体的分子内环加成
• New Entry to γ-Butyrolactams by Free Radical Cyclization of<i>N</i>-Allyl-α-chloro-α-(methylthio)acetamides. Formal Total Synthesis of (±)-Pseudoheliotridane
  作者：Hiroyuki Ishibashi、Tatsunori Sato、Maki Irie、Suzumi Harada、Masazumi Ikeda

  DOI：10.1246/cl.1987.795

  日期：1987.5.5

  Tributyltin hydride-azobisisobutyronitrile induced radical cyclization of N-allyl-α-chloro-α-(methylthio)acetamides afforded γ-butyrolactams. This method was applied to the formal total synthesis of (±)-pseudoheliotridane.

  三丁基氢化锡-偶氮二异丁腈诱导 N-烯丙基-α-氯-α-（甲硫基）乙酰胺的自由基环化，得到 γ-丁内酰胺。将该方法应用于(±)-pseudoheliotridane的正式全合成。
• Selective Estrogen Receptor Modulator
  申请人：Hamaoka Shinichi

  公开号：US20120004315A1

  公开（公告）日：2012-01-05

  The present invention provides a compound represented by the following formula (I); [wherein T represents a single bond, a C1-C4 alkylene group which may have a substituent and the like; formula (I-1) represents a single bond or a double bond; A represents a single bond, a bivalent 5- to 14-membered heterocyclic group which may have a substituent and the like; Y represents a single bond and the like; Z represents a methylene group and the like; ring G represents a phenylene group and the like which may condense with a 5- to 6-membered ring and may have a heteroatom; R a and R b are the same as or different from each other and represent a hydrogen atom and the like; W represents a single bond and the like; R′ represents 1 to 4 independent hydrogen atoms and the like; and R″ represents 1 to 4 independent hydrogen atoms and the like] or a salt thereof, or a hydrate thereof.

  本发明提供一种由以下式（I）表示的化合物; [其中T表示单键，可能具有取代基的C1-C4烷基和类似物；式（I-1）表示单键或双键；A表示单键，可能具有取代基的双价5-至14-成员杂环基和类似物；Y表示单键和类似物；Z表示亚甲基基团和类似物；环G表示苯基团和类似物，可能与5-至6-成员环缩合并可能具有杂原子；Ra和Rb相同或不同，表示氢原子和类似物；W表示单键和类似物；R'表示1到4个独立的氢原子和类似物；R''表示1到4个独立的氢原子和类似物]或其盐或水合物。
• Selective estrogen receptor modulator
  申请人：Hamaoka Shinichi

  公开号：US20060116364A1

  公开（公告）日：2006-06-01

  The present invention provides a compound represented by the following formula [wherein T represents a single bond, a C1-C4 alkylene group which may have a substituent and the like; formula (I-1) represents a single bond or a double bond; A represents a single bond, a bivalent 5- to 14-membered heterocyclic group which may have a substituent and the like; Y represents a single bond and the like; Z represents a methylene group and the like; ring G represents a phenylene group and the like which may condense with a 5- to 6-membered ring and may have a heteroatom; R a and R b are the same as or different from each other and represent a hydrogen atom and the like; W represents a single bond and the like; R′ represents 1 to 4 independent hydrogen atoms and the like; and R″ represents 1 to 4 independent hydrogen atoms and the like] or a salt thereof, or a hydrate thereof

  本发明提供了一种化合物，其表示为以下式子[其中T表示单键，C1-C4的烷基，可能带有取代基等；式(I-1)表示单键或双键；A表示单键，二价的5-至14-成员杂环基团，可能带有取代基等；Y表示单键等；Z表示亚甲基等；环G表示苯基团等，可与5-至6-成员环缩合并且可能具有杂原子；Ra和Rb相同或不同，表示氢原子等；W表示单键等；R'表示1至4个独立的氢原子等；R"表示1至4个独立的氢原子等]或其盐，或其水合物。